Clinical trial
A Study of the Safety and Efficacy of Memantine in Moderate to Severe…
NCT00322153 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00322153 |
|---|---|
| Title | A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine in Patients With Moderate-to-Severe Dementia of the Alzheimer's Type |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dementia of the Alzheimer's Type |
| Intervention type | Drug |
| Interventions | memantine ER, Placebo |
| Enrollment | 677 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | May 5, 2006 |
| Last update posted | Sep 16, 2010 |
| Countries | Argentina, Chile, Mexico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: